Market Analysis and Insights: Global Non-opioid Pain Patches Market
The global Non-opioid Pain Patches market size is projected to reach US$ 779.5 million by 2027, from US$ 668.2 million in 2020, at a CAGR of 2.6% during 2021-2027.
Global Non-opioid Pain Patches Scope and Segment
The global Non-opioid Pain Patches market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-opioid Pain Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Others
By the end users/application, this report covers the following segments
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the Non-opioid Pain Patches market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Non-opioid Pain Patches key manufacturers in this market include:
Pfizer
GlaxoSmithKline
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International
The global Non-opioid Pain Patches market size is projected to reach US$ 779.5 million by 2027, from US$ 668.2 million in 2020, at a CAGR of 2.6% during 2021-2027.
Global Non-opioid Pain Patches Scope and Segment
The global Non-opioid Pain Patches market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-opioid Pain Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Others
By the end users/application, this report covers the following segments
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the Non-opioid Pain Patches market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Non-opioid Pain Patches key manufacturers in this market include:
Pfizer
GlaxoSmithKline
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International
1 Non-opioid Pain Patches Market Overview
1.1 Non-opioid Pain Patches Product Overview
1.2 Non-opioid Pain Patches Market Segment by Type
1.2.1 Lidocaine Patch
1.2.2 Diclofenac Patch
1.2.3 Methyl Salicylate Patch
1.2.4 Capsaicin Patch
1.2.5 Ketoprofen Patch
1.2.6 Others
1.3 Global Non-opioid Pain Patches Market Size by Type
1.3.1 Global Non-opioid Pain Patches Market Size Overview by Type (2016-2027)
1.3.2 Global Non-opioid Pain Patches Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Non-opioid Pain Patches Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Non-opioid Pain Patches Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Non-opioid Pain Patches Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Non-opioid Pain Patches Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Non-opioid Pain Patches Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Non-opioid Pain Patches Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Non-opioid Pain Patches Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Non-opioid Pain Patches Sales Breakdown by Type (2016-2021)
1.4.2 Europe Non-opioid Pain Patches Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Non-opioid Pain Patches Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Non-opioid Pain Patches Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Non-opioid Pain Patches Sales Breakdown by Type (2016-2021)
2 Global Non-opioid Pain Patches Market Competition by Company
2.1 Global Top Players by Non-opioid Pain Patches Sales (2016-2021)
2.2 Global Top Players by Non-opioid Pain Patches Revenue (2016-2021)
2.3 Global Top Players Non-opioid Pain Patches Price (2016-2021)
2.4 Global Top Manufacturers Non-opioid Pain Patches Manufacturing Base Distribution, Sales Area, Product Type
2.5 Non-opioid Pain Patches Market Competitive Situation and Trends
2.5.1 Non-opioid Pain Patches Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Non-opioid Pain Patches Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-opioid Pain Patches as of 2020)
2.7 Date of Key Manufacturers Enter into Non-opioid Pain Patches Market
2.8 Key Manufacturers Non-opioid Pain Patches Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Non-opioid Pain Patches Status and Outlook by Region
3.1 Global Non-opioid Pain Patches Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Non-opioid Pain Patches Historic Market Size by Region
3.2.1 Global Non-opioid Pain Patches Sales in Volume by Region (2016-2021)
3.2.2 Global Non-opioid Pain Patches Sales in Value by Region (2016-2021)
3.2.3 Global Non-opioid Pain Patches Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Non-opioid Pain Patches Forecasted Market Size by Region
3.3.1 Global Non-opioid Pain Patches Sales in Volume by Region (2022-2027)
3.3.2 Global Non-opioid Pain Patches Sales in Value by Region (2022-2027)
3.3.3 Global Non-opioid Pain Patches Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Non-opioid Pain Patches by Application
4.1 Non-opioid Pain Patches Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Independent Pharmacies & Drug Stores
4.1.3 Online Pharmacies
4.2 Global Non-opioid Pain Patches Market Size by Application
4.2.1 Global Non-opioid Pain Patches Market Size Overview by Application (2016-2027)
4.2.2 Global Non-opioid Pain Patches Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Non-opioid Pain Patches Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Non-opioid Pain Patches Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Non-opioid Pain Patches Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Non-opioid Pain Patches Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Non-opioid Pain Patches Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Non-opioid Pain Patches Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Non-opioid Pain Patches Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Non-opioid Pain Patches Sales Breakdown by Application (2016-2021)
4.3.2 Europe Non-opioid Pain Patches Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Non-opioid Pain Patches Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Non-opioid Pain Patches Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Non-opioid Pain Patches Sales Breakdown by Application (2016-2021)
5 North America Non-opioid Pain Patches by Country
5.1 North America Non-opioid Pain Patches Historic Market Size by Country
5.1.1 North America Non-opioid Pain Patches Sales in Volume by Country (2016-2021)
5.1.2 North America Non-opioid Pain Patches Sales in Value by Country (2016-2021)
5.2 North America Non-opioid Pain Patches Forecasted Market Size by Country
5.2.1 North America Non-opioid Pain Patches Sales in Volume by Country (2022-2027)
5.2.2 North America Non-opioid Pain Patches Sales in Value by Country (2022-2027)
6 Europe Non-opioid Pain Patches by Country
6.1 Europe Non-opioid Pain Patches Historic Market Size by Country
6.1.1 Europe Non-opioid Pain Patches Sales in Volume by Country (2016-2021)
6.1.2 Europe Non-opioid Pain Patches Sales in Value by Country (2016-2021)
6.2 Europe Non-opioid Pain Patches Forecasted Market Size by Country
6.2.1 Europe Non-opioid Pain Patches Sales in Volume by Country (2022-2027)
6.2.2 Europe Non-opioid Pain Patches Sales in Value by Country (2022-2027)
7 Asia-Pacific Non-opioid Pain Patches by Region
7.1 Asia-Pacific Non-opioid Pain Patches Historic Market Size by Region
7.1.1 Asia-Pacific Non-opioid Pain Patches Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Non-opioid Pain Patches Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Non-opioid Pain Patches Forecasted Market Size by Region
7.2.1 Asia-Pacific Non-opioid Pain Patches Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Non-opioid Pain Patches Sales in Value by Region (2022-2027)
8 Latin America Non-opioid Pain Patches by Country
8.1 Latin America Non-opioid Pain Patches Historic Market Size by Country
8.1.1 Latin America Non-opioid Pain Patches Sales in Volume by Country (2016-2021)
8.1.2 Latin America Non-opioid Pain Patches Sales in Value by Country (2016-2021)
8.2 Latin America Non-opioid Pain Patches Forecasted Market Size by Country
8.2.1 Latin America Non-opioid Pain Patches Sales in Volume by Country (2022-2027)
8.2.2 Latin America Non-opioid Pain Patches Sales in Value by Country (2022-2027)
9 Middle East and Africa Non-opioid Pain Patches by Country
9.1 Middle East and Africa Non-opioid Pain Patches Historic Market Size by Country
9.1.1 Middle East and Africa Non-opioid Pain Patches Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Non-opioid Pain Patches Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Non-opioid Pain Patches Forecasted Market Size by Country
9.2.1 Middle East and Africa Non-opioid Pain Patches Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Non-opioid Pain Patches Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Non-opioid Pain Patches Business
10.1 Pfizer
10.1.1 Pfizer Corporation Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Pfizer Non-opioid Pain Patches Products Offered
10.1.5 Pfizer Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Corporation Information
10.2.2 GlaxoSmithKline Introduction and Business Overview
10.2.3 GlaxoSmithKline Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Pfizer Non-opioid Pain Patches Products Offered
10.2.5 GlaxoSmithKline Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Corporation Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Johnson & Johnson Non-opioid Pain Patches Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 Novartis AG
10.4.1 Novartis AG Corporation Information
10.4.2 Novartis AG Introduction and Business Overview
10.4.3 Novartis AG Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Novartis AG Non-opioid Pain Patches Products Offered
10.4.5 Novartis AG Recent Development
10.5 Mylan N.V.
10.5.1 Mylan N.V. Corporation Information
10.5.2 Mylan N.V. Introduction and Business Overview
10.5.3 Mylan N.V. Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Mylan N.V. Non-opioid Pain Patches Products Offered
10.5.5 Mylan N.V. Recent Development
10.6 Teva Pharmaceutical Industries
10.6.1 Teva Pharmaceutical Industries Corporation Information
10.6.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Teva Pharmaceutical Industries Non-opioid Pain Patches Products Offered
10.6.5 Teva Pharmaceutical Industries Recent Development
10.7 Hisamitsu Pharmaceutical
10.7.1 Hisamitsu Pharmaceutical Corporation Information
10.7.2 Hisamitsu Pharmaceutical Introduction and Business Overview
10.7.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Hisamitsu Pharmaceutical Non-opioid Pain Patches Products Offered
10.7.5 Hisamitsu Pharmaceutical Recent Development
10.8 TEH SENG Pharmaceutical
10.8.1 TEH SENG Pharmaceutical Corporation Information
10.8.2 TEH SENG Pharmaceutical Introduction and Business Overview
10.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.8.4 TEH SENG Pharmaceutical Non-opioid Pain Patches Products Offered
10.8.5 TEH SENG Pharmaceutical Recent Development
10.9 Teikoku Seiyaku
10.9.1 Teikoku Seiyaku Corporation Information
10.9.2 Teikoku Seiyaku Introduction and Business Overview
10.9.3 Teikoku Seiyaku Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Teikoku Seiyaku Non-opioid Pain Patches Products Offered
10.9.5 Teikoku Seiyaku Recent Development
10.10 IBSA Institut Biochimque SA
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Non-opioid Pain Patches Product Category, Application and Specification
10.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 IBSA Institut Biochimque SA Recent Development
10.11 Acorda Therapeutics
10.11.1 Acorda Therapeutics Corporation Information
10.11.2 Acorda Therapeutics Introduction and Business Overview
10.11.3 Acorda Therapeutics Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Acorda Therapeutics Non-opioid Pain Patches Products Offered
10.11.5 Acorda Therapeutics Recent Development
10.12 Allergan PLC
10.12.1 Allergan PLC Corporation Information
10.12.2 Allergan PLC Introduction and Business Overview
10.12.3 Allergan PLC Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Allergan PLC Non-opioid Pain Patches Products Offered
10.12.5 Allergan PLC Recent Development
10.13 Endo International
10.13.1 Endo International Corporation Information
10.13.2 Endo International Introduction and Business Overview
10.13.3 Endo International Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Endo International Non-opioid Pain Patches Products Offered
10.13.5 Endo International Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Non-opioid Pain Patches Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Non-opioid Pain Patches Industrial Chain Analysis
11.4 Non-opioid Pain Patches Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Non-opioid Pain Patches Distributors
12.3 Non-opioid Pain Patches Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Non-opioid Pain Patches Product Overview
1.2 Non-opioid Pain Patches Market Segment by Type
1.2.1 Lidocaine Patch
1.2.2 Diclofenac Patch
1.2.3 Methyl Salicylate Patch
1.2.4 Capsaicin Patch
1.2.5 Ketoprofen Patch
1.2.6 Others
1.3 Global Non-opioid Pain Patches Market Size by Type
1.3.1 Global Non-opioid Pain Patches Market Size Overview by Type (2016-2027)
1.3.2 Global Non-opioid Pain Patches Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Non-opioid Pain Patches Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Non-opioid Pain Patches Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Non-opioid Pain Patches Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Non-opioid Pain Patches Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Non-opioid Pain Patches Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Non-opioid Pain Patches Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Non-opioid Pain Patches Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Non-opioid Pain Patches Sales Breakdown by Type (2016-2021)
1.4.2 Europe Non-opioid Pain Patches Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Non-opioid Pain Patches Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Non-opioid Pain Patches Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Non-opioid Pain Patches Sales Breakdown by Type (2016-2021)
2 Global Non-opioid Pain Patches Market Competition by Company
2.1 Global Top Players by Non-opioid Pain Patches Sales (2016-2021)
2.2 Global Top Players by Non-opioid Pain Patches Revenue (2016-2021)
2.3 Global Top Players Non-opioid Pain Patches Price (2016-2021)
2.4 Global Top Manufacturers Non-opioid Pain Patches Manufacturing Base Distribution, Sales Area, Product Type
2.5 Non-opioid Pain Patches Market Competitive Situation and Trends
2.5.1 Non-opioid Pain Patches Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Non-opioid Pain Patches Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-opioid Pain Patches as of 2020)
2.7 Date of Key Manufacturers Enter into Non-opioid Pain Patches Market
2.8 Key Manufacturers Non-opioid Pain Patches Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Non-opioid Pain Patches Status and Outlook by Region
3.1 Global Non-opioid Pain Patches Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Non-opioid Pain Patches Historic Market Size by Region
3.2.1 Global Non-opioid Pain Patches Sales in Volume by Region (2016-2021)
3.2.2 Global Non-opioid Pain Patches Sales in Value by Region (2016-2021)
3.2.3 Global Non-opioid Pain Patches Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Non-opioid Pain Patches Forecasted Market Size by Region
3.3.1 Global Non-opioid Pain Patches Sales in Volume by Region (2022-2027)
3.3.2 Global Non-opioid Pain Patches Sales in Value by Region (2022-2027)
3.3.3 Global Non-opioid Pain Patches Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Non-opioid Pain Patches by Application
4.1 Non-opioid Pain Patches Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Independent Pharmacies & Drug Stores
4.1.3 Online Pharmacies
4.2 Global Non-opioid Pain Patches Market Size by Application
4.2.1 Global Non-opioid Pain Patches Market Size Overview by Application (2016-2027)
4.2.2 Global Non-opioid Pain Patches Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Non-opioid Pain Patches Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Non-opioid Pain Patches Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Non-opioid Pain Patches Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Non-opioid Pain Patches Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Non-opioid Pain Patches Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Non-opioid Pain Patches Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Non-opioid Pain Patches Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Non-opioid Pain Patches Sales Breakdown by Application (2016-2021)
4.3.2 Europe Non-opioid Pain Patches Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Non-opioid Pain Patches Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Non-opioid Pain Patches Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Non-opioid Pain Patches Sales Breakdown by Application (2016-2021)
5 North America Non-opioid Pain Patches by Country
5.1 North America Non-opioid Pain Patches Historic Market Size by Country
5.1.1 North America Non-opioid Pain Patches Sales in Volume by Country (2016-2021)
5.1.2 North America Non-opioid Pain Patches Sales in Value by Country (2016-2021)
5.2 North America Non-opioid Pain Patches Forecasted Market Size by Country
5.2.1 North America Non-opioid Pain Patches Sales in Volume by Country (2022-2027)
5.2.2 North America Non-opioid Pain Patches Sales in Value by Country (2022-2027)
6 Europe Non-opioid Pain Patches by Country
6.1 Europe Non-opioid Pain Patches Historic Market Size by Country
6.1.1 Europe Non-opioid Pain Patches Sales in Volume by Country (2016-2021)
6.1.2 Europe Non-opioid Pain Patches Sales in Value by Country (2016-2021)
6.2 Europe Non-opioid Pain Patches Forecasted Market Size by Country
6.2.1 Europe Non-opioid Pain Patches Sales in Volume by Country (2022-2027)
6.2.2 Europe Non-opioid Pain Patches Sales in Value by Country (2022-2027)
7 Asia-Pacific Non-opioid Pain Patches by Region
7.1 Asia-Pacific Non-opioid Pain Patches Historic Market Size by Region
7.1.1 Asia-Pacific Non-opioid Pain Patches Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Non-opioid Pain Patches Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Non-opioid Pain Patches Forecasted Market Size by Region
7.2.1 Asia-Pacific Non-opioid Pain Patches Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Non-opioid Pain Patches Sales in Value by Region (2022-2027)
8 Latin America Non-opioid Pain Patches by Country
8.1 Latin America Non-opioid Pain Patches Historic Market Size by Country
8.1.1 Latin America Non-opioid Pain Patches Sales in Volume by Country (2016-2021)
8.1.2 Latin America Non-opioid Pain Patches Sales in Value by Country (2016-2021)
8.2 Latin America Non-opioid Pain Patches Forecasted Market Size by Country
8.2.1 Latin America Non-opioid Pain Patches Sales in Volume by Country (2022-2027)
8.2.2 Latin America Non-opioid Pain Patches Sales in Value by Country (2022-2027)
9 Middle East and Africa Non-opioid Pain Patches by Country
9.1 Middle East and Africa Non-opioid Pain Patches Historic Market Size by Country
9.1.1 Middle East and Africa Non-opioid Pain Patches Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Non-opioid Pain Patches Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Non-opioid Pain Patches Forecasted Market Size by Country
9.2.1 Middle East and Africa Non-opioid Pain Patches Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Non-opioid Pain Patches Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Non-opioid Pain Patches Business
10.1 Pfizer
10.1.1 Pfizer Corporation Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Pfizer Non-opioid Pain Patches Products Offered
10.1.5 Pfizer Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Corporation Information
10.2.2 GlaxoSmithKline Introduction and Business Overview
10.2.3 GlaxoSmithKline Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Pfizer Non-opioid Pain Patches Products Offered
10.2.5 GlaxoSmithKline Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Corporation Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Johnson & Johnson Non-opioid Pain Patches Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 Novartis AG
10.4.1 Novartis AG Corporation Information
10.4.2 Novartis AG Introduction and Business Overview
10.4.3 Novartis AG Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Novartis AG Non-opioid Pain Patches Products Offered
10.4.5 Novartis AG Recent Development
10.5 Mylan N.V.
10.5.1 Mylan N.V. Corporation Information
10.5.2 Mylan N.V. Introduction and Business Overview
10.5.3 Mylan N.V. Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Mylan N.V. Non-opioid Pain Patches Products Offered
10.5.5 Mylan N.V. Recent Development
10.6 Teva Pharmaceutical Industries
10.6.1 Teva Pharmaceutical Industries Corporation Information
10.6.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Teva Pharmaceutical Industries Non-opioid Pain Patches Products Offered
10.6.5 Teva Pharmaceutical Industries Recent Development
10.7 Hisamitsu Pharmaceutical
10.7.1 Hisamitsu Pharmaceutical Corporation Information
10.7.2 Hisamitsu Pharmaceutical Introduction and Business Overview
10.7.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Hisamitsu Pharmaceutical Non-opioid Pain Patches Products Offered
10.7.5 Hisamitsu Pharmaceutical Recent Development
10.8 TEH SENG Pharmaceutical
10.8.1 TEH SENG Pharmaceutical Corporation Information
10.8.2 TEH SENG Pharmaceutical Introduction and Business Overview
10.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.8.4 TEH SENG Pharmaceutical Non-opioid Pain Patches Products Offered
10.8.5 TEH SENG Pharmaceutical Recent Development
10.9 Teikoku Seiyaku
10.9.1 Teikoku Seiyaku Corporation Information
10.9.2 Teikoku Seiyaku Introduction and Business Overview
10.9.3 Teikoku Seiyaku Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Teikoku Seiyaku Non-opioid Pain Patches Products Offered
10.9.5 Teikoku Seiyaku Recent Development
10.10 IBSA Institut Biochimque SA
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Non-opioid Pain Patches Product Category, Application and Specification
10.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 IBSA Institut Biochimque SA Recent Development
10.11 Acorda Therapeutics
10.11.1 Acorda Therapeutics Corporation Information
10.11.2 Acorda Therapeutics Introduction and Business Overview
10.11.3 Acorda Therapeutics Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Acorda Therapeutics Non-opioid Pain Patches Products Offered
10.11.5 Acorda Therapeutics Recent Development
10.12 Allergan PLC
10.12.1 Allergan PLC Corporation Information
10.12.2 Allergan PLC Introduction and Business Overview
10.12.3 Allergan PLC Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Allergan PLC Non-opioid Pain Patches Products Offered
10.12.5 Allergan PLC Recent Development
10.13 Endo International
10.13.1 Endo International Corporation Information
10.13.2 Endo International Introduction and Business Overview
10.13.3 Endo International Non-opioid Pain Patches Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Endo International Non-opioid Pain Patches Products Offered
10.13.5 Endo International Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Non-opioid Pain Patches Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Non-opioid Pain Patches Industrial Chain Analysis
11.4 Non-opioid Pain Patches Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Non-opioid Pain Patches Distributors
12.3 Non-opioid Pain Patches Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
